HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective versus total biliary drainage for obstructive jaundice caused by a hepatobiliary malignancy.

AbstractBACKGROUND:
Controversy exists regarding which approach is preferable among types of biliary drainage for obstructive jaundice before major hepatectomy: selective biliary drainage (SBD) only on the future remnant liver (FRL) or total biliary drainage (TBD).
METHODS:
There were 42 consecutive patients who underwent SBD (n = 15) or TBD (n = 27) for obstructive jaundice caused by a hepatobiliary malignancy, and subsequent portal vein embolization (PVE) before extended hemihepatectomy. The hypertrophy ratio, defined as the ratio of the FRL volume after PVE to that before PVE, was evaluated. The bilirubin clearance also was calculated.
RESULTS:
The hypertrophy ratio was higher in patients with SBD than in those with TBD (median, 128%; range, 111-152% vs median, 121%; range, 102-138%; P = .013). The bilirubin clearance of FRL with SBD was markedly improved after PVE compared with that in patients with TBD.
CONCLUSIONS:
SBD is superior to TBD in promoting hypertrophy of the FRL induced by PVE and in guaranteeing good liver function before major hepatectomy.
AuthorsTakeaki Ishizawa, Kiyoshi Hasegawa, Keiji Sano, Hiroshi Imamura, Norihiro Kokudo, Masatoshi Makuuchi
JournalAmerican journal of surgery (Am J Surg) Vol. 193 Issue 2 Pg. 149-54 (Feb 2007) ISSN: 1879-1883 [Electronic] United States
PMID17236839 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biliary Tract Neoplasms (complications)
  • Biliary Tract Surgical Procedures (methods)
  • Drainage (methods)
  • Embolization, Therapeutic
  • Female
  • Hepatectomy
  • Humans
  • Jaundice, Obstructive (etiology, surgery)
  • Liver Neoplasms (complications)
  • Male
  • Middle Aged
  • Neoplastic Cells, Circulating
  • Portal Vein
  • Preoperative Care
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: